Suchergebnisse - "Cappello, Maria"

PubPharm (8)

1

Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19

enthalten in: Inflammatory bowel diseases | 2023

von Macaluso, F. | Giuliano, A. | Fries, W. | +22

2

Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy : A Cross-Sectional Survey

enthalten in: Inflammatory bowel diseases | 2021

von Crispino, F. | Brinch, D. | Carrozza, L. | +1

3

The SPOSIB SB2 Sicilian Cohort : Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches

enthalten in: Inflammatory bowel diseases | 2021

von Macaluso, F. | Fries, W. | Viola, A. | +19

4

Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients : Results From the SoCOVID-19 Survey

enthalten in: Inflammatory bowel diseases | 2020

von Fantini, M. | Biancone, L. | Dragoni, G. | +43

5

The PROSIT Cohort of Infliximab Biosimilar in IBD : A Prolonged Follow-up on the Effectiveness and Safety Across Italy

enthalten in: Inflammatory bowel diseases | 2019

von Armuzzi, A. | Fiorino, G. | Variola, A. | +30

6

Adalimumab in steroid-dependent Crohn's disease patients : prognostic factors for clinical benefit

enthalten in: Inflammatory bowel diseases | 2012

von Orlando, A. | Renna, S. | Mocciaro, F. | +4

7

Adalimumab in steroid‐dependent Crohn's disease patients: Prognostic factors for clinical benefit

enthalten in: Inflammatory bowel diseases | 2012

von Orlando, A. | Renna, S. | Mocciaro, F. | +4

8

Splenic tuberculosis in a patient with Crohn's disease on infliximab : case report

enthalten in: Inflammatory bowel diseases | 2010

von Cappello, M. | Randazzo, C. | Rizzuto, G. | +3

1
[1]